Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Filed Nov 13, 2020 · 10-Q · 44 days after period end · 0001193125-20-292209
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $55.00K | $33.00K |
| Net Income | -$2.72M | -$1.15M |
| EPS Diluted | -$2.45 | -$1.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 13, 2020 · 44 d after period end
